Business Description
![ADMA Biologics Inc ADMA Biologics Inc logo](https://static.gurufocus.com/logos/0C00009U7W.png?14)
ADMA Biologics Inc
NAICS : 325412
SIC : 2834
ISIN : US0008991046
Share Class Description:
ADMA: Ordinary SharesDescription
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 0.92 | |||||
Debt-to-EBITDA | 5.04 | |||||
Interest Coverage | 1.95 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 9.03 | |||||
Beneish M-Score | -1.89 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 33 | |||||
3-Year EPS without NRI Growth Rate | 75.6 | |||||
3-Year Book Growth Rate | -10.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 21.87 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.93 | |||||
9-Day RSI | 56.87 | |||||
14-Day RSI | 62.83 | |||||
6-1 Month Momentum % | 112.97 | |||||
12-1 Month Momentum % | 178.66 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.21 | |||||
Quick Ratio | 1.86 | |||||
Cash Ratio | 0.85 | |||||
Days Inventory | 357.05 | |||||
Days Sales Outstanding | 44.24 | |||||
Days Payable | 29.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -29.2 | |||||
Shareholder Yield % | 0.22 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 39.39 | |||||
Operating Margin % | 15.63 | |||||
Net Margin % | -1.29 | |||||
FCF Margin % | 5.62 | |||||
ROE % | -2.49 | |||||
ROA % | -1.06 | |||||
ROIC % | 21.94 | |||||
ROC (Joel Greenblatt) % | 8.59 | |||||
ROCE % | 6.59 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 35.44 | |||||
PE Ratio without NRI | 137.08 | |||||
PS Ratio | 10.62 | |||||
PB Ratio | 19.94 | |||||
Price-to-Tangible-Book | 20.25 | |||||
Price-to-Free-Cash-Flow | 183.29 | |||||
Price-to-Operating-Cash-Flow | 138.91 | |||||
EV-to-EBIT | 159.35 | |||||
EV-to-EBITDA | 111.54 | |||||
EV-to-Revenue | 11.05 | |||||
EV-to-Forward-Revenue | 8.67 | |||||
EV-to-FCF | 196.65 | |||||
Price-to-Median-PS-Value | 1.94 | |||||
Price-to-Graham-Number | 11.15 | |||||
Price-to-Net-Current-Asset-Value | 38.71 | |||||
Earnings Yield (Greenblatt) % | 0.63 | |||||
FCF Yield % | 0.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ADMA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ADMA Biologics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 283.177 | ||
EPS (TTM) ($) | -0.02 | ||
Beta | 0.8 | ||
Volatility % | 54.53 | ||
14-Day RSI | 62.83 | ||
14-Day ATR ($) | 0.436755 | ||
20-Day SMA ($) | 12.484 | ||
12-1 Month Momentum % | 178.66 | ||
52-Week Range ($) | 3.06 - 14.03 | ||
Shares Outstanding (Mil) | 231.81 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ADMA Biologics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ADMA Biologics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
ADMA Biologics Inc Frequently Asked Questions
What is ADMA Biologics Inc(ADMA)'s stock price today?
The current price of ADMA is $13.16. The 52 week high of ADMA is $14.03 and 52 week low is $3.06.
When is next earnings date of ADMA Biologics Inc(ADMA)?
The next earnings date of ADMA Biologics Inc(ADMA) is 2024-08-09 Est..
Does ADMA Biologics Inc(ADMA) pay dividends? If so, how much?
ADMA Biologics Inc(ADMA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |